These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19954345)

  • 41. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
    Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
    Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis.
    Lee E; Wei Y; Zou Z; Tucker K; Rakheja D; Levine B; Amatruda JF
    Oncotarget; 2016 Oct; 7(42):67919-67933. PubMed ID: 27655644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
    Colombino M; Capone M; Lissia A; Cossu A; Rubino C; De Giorgi V; Massi D; Fonsatti E; Staibano S; Nappi O; Pagani E; Casula M; Manca A; Sini M; Franco R; Botti G; Caracò C; Mozzillo N; Ascierto PA; Palmieri G
    J Clin Oncol; 2012 Jul; 30(20):2522-9. PubMed ID: 22614978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mosaic zebrafish transgenesis for functional genomic analysis of candidate cooperative genes in tumor pathogenesis.
    Ung CY; Guo F; Zhang X; Zhu Z; Zhu S
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of p53 protein in melanoma progression.
    Kanoko M; Ueda M; Nagano T; Ichihashi M
    J Dermatol Sci; 1996 Jun; 12(2):97-103. PubMed ID: 8814540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.
    Caulin C; Nguyen T; Lang GA; Goepfert TM; Brinkley BR; Cai WW; Lozano G; Roop DR
    J Clin Invest; 2007 Jul; 117(7):1893-901. PubMed ID: 17607363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of prdm1a accelerates melanoma onset and progression.
    Iwanaga R; Truong BT; Hsu JY; Lambert KA; Vyas R; Orlicky D; Shellman YG; Tan AC; Ceol C; Artinger KB
    Mol Carcinog; 2020 Sep; 59(9):1052-1063. PubMed ID: 32562448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.
    Posch C; Cholewa BD; Vujic I; Sanlorenzo M; Ma J; Kim ST; Kleffel S; Schatton T; Rappersberger K; Gutteridge R; Ahmad N; Ortiz/Urda S
    J Invest Dermatol; 2015 Oct; 135(10):2475-2483. PubMed ID: 26016894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
    Rinner B; Gandolfi G; Meditz K; Frisch MT; Wagner K; Ciarrocchi A; Torricelli F; Koivuniemi R; Niklander J; Liegl-Atzwanger B; Lohberger B; Heitzer E; Ghaffari-Tabrizi-Wizsy N; Zweytick D; Zalaudek I
    Sci Rep; 2017 May; 7(1):2098. PubMed ID: 28522871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
    Goel VK; Lazar AJ; Warneke CL; Redston MS; Haluska FG
    J Invest Dermatol; 2006 Jan; 126(1):154-60. PubMed ID: 16417231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Searching for the Chokehold of NRAS Mutant Melanoma.
    Posch C; Vujic I; Monshi B; Sanlorenzo M; Weihsengruber F; Rappersberger K; Ortiz-Urda S
    J Invest Dermatol; 2016 Jul; 136(7):1330-1336. PubMed ID: 27160069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation and expression of TP53 in malignant melanomas.
    Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
    Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an Undergraduate Cell Biology Laboratory to Assess Pigmentation and Cell Size in a Zebrafish Model of Uveal Melanoma.
    Henle AM
    Zebrafish; 2024 Apr; 21(2):137-143. PubMed ID: 38621208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
    Ferguson B; Ram R; Handoko HY; Mukhopadhyay P; Muller HK; Soyer HP; Morahan G; Walker GJ
    Oncogene; 2015 May; 34(22):2879-86. PubMed ID: 25088201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 59. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
    J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.